Loading
Latest filing published 27 May 2014 for Plandai Biotechnology, Inc., €259k.
No signal scores available.
Brian Johnson discloses dealings in Plandai Biotechnology, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 30 March 2012 and the latest from 1 January 2014.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 27 May 2014 came the latest disclosure, a share grant for €10k in Plandai Biotechnology, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration